Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.59 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.59 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.59 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10440174 | 0.83 | EPHX1 (0.50) | TAAR1SIGMAR1SLC18A2TRPA1NPC1 | |
| SCHEMBL16095412 | 0.80 | TAAR1 (0.52) | TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11147449 | 0.80 | SIGMAR1 (0.52) | TAAR1SIGMAR1SLC18A2TRPA1NPC1 | |
| SCHEMBL20168603 | 0.80 | TAAR1 (0.52) | TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3936936 | 0.79 | CYP1A2 (0.46) | TAAR1SIGMAR1SLC18A2TRPA1NPC1 | |
| SCHEMBL28127137 | 0.79 | CYP1A2 (0.46) | TAAR1SIGMAR1SLC18A2TRPA1NPC1 | |
| SCHEMBL10676875 | 0.78 | SIGMAR1 (0.62) | TAAR1SIGMAR1SLC18A2TRPA1NPC1 | |
| SCHEMBL8722485 | 0.78 | SLC6A2 (0.53) | TAAR1SIGMAR1SLC18A2SLC6A2SLC6A4 | |
| SCHEMBL4228132 | 0.78 | SLC6A2 (0.53) | TAAR1SIGMAR1SLC18A2SLC6A2SLC6A4 | |
| SCHEMBL19041104 | 0.78 | ALDH1A1 (0.46) | TAAR1SIGMAR1SLC18A2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107266447-A | A kind of preparation method of Mirtazapine | 江西永通科技股份有限公司 | 2017-10-20 | — | — | CN | claimed |
| EP-4181781-B1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIV KINDERSPITAL BEIDER BASEL (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-20230277125-A1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIVERSITÄTS-KINDERSPITAL BEIDER BASEL (CH) | 2023-09-07 | — | — | US | disclosed |
| EP-3224237-A1 | NECROSIS INHIBITORS | National Institute Of Biological Sciences, Beijing (CN) | 2017-10-04 | — | — | EP | disclosed |
| WO-2016101885-A1 | NECROSIS INHIBITORS | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2016-06-30 | — | — | WO | disclosed |
| EP-1348696-B1 | Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same | INST MATERIA MEDICA CAMS (CN) | 2012-02-01 | — | — | EP | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
| WO-2009126635-A1 | 2-AMINO-BENZOTHIAZOLE DERIVATES USEFUL AS INHIBITORS OF ROCK KINASES | ABBOTT LABORATORIES (US) | 2009-10-15 | — | — | WO | disclosed |
| US-6787564-B2 | FOR TREATING HYPOXIA PROTECTIVE, NOOTROPIC AND NEURODEGENERATIVE DISEASES (CERBRAL ISCHEMIA, ALZHEIMER'S DISEASE, AND VASCULAR DEMENTIA) | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2004-09-07 | — | — | US | disclosed |
| WO-2004022568-A1 | ARYL-ETHANOLAMINE DERIVATIVES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES | 2003-11-06 | — | — | US | disclosed |
| EP-1348696-A1 | Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2003-10-01 | — | — | EP | disclosed |
| EP-0881210-B1 | Process for the production of N,N-dialkylaminophenyl alkanols | CIBA SC HOLDING AG (CH) | 2001-11-21 | — | — | EP | disclosed |
| US-5962739-A | Process for the preparation of N,N- dialkylaminophenyl alkanols | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-10-05 | — | — | US | disclosed |
| EP-0881210-A1 | Process for the production of N,N-dialkylaminophenyl alkanols | Ciba SC Holding AG (CH) | 1998-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | HIF1AN, HIF1A, CLN6 | TAAR1 2946/4885SIGMAR1 1270/4885SLC18A2 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.